FIND, India Health Fund to support testing efforts for COVID-19, TB in Mumbai biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
59 Hepatitis treatment centres established in Punjab: Balbir Singh Sidhu
PUNJAB NEWS EXPRESS | February 15, 2021 05:34 PM
CHANDIGARH: In view of extending the medical benefits to high-risk groups, the Punjab Government established the 59 Hepatitis treatment centres from 2017 to 2020 in State and it is matter of pride, on Punjab model GoI has developed National Viral Hepatitis Control Programme (NVHCP) to treat such patients across the country.
The Health Minister Mr. Balbir Singh Sidhu informed that Punjab was the first State to initiate free of cost treatment of Hepatitis C in country. Till date 1.83 lakh persons have been screened for Hepatitis C in the State and 91, 403 patients have been initiated on free treatment of Hepatitis C. All 59 treatment centers are actively functional at 22 District Hospitals, 3 GMCs, 13 ART centers, 11 OST sites, 9 Central Prisons and 1 SDH.
Chandigarh (Punjab) [India], February 15 (ANI): In view of extending the medical benefits to high-risk groups, the Punjab government established 59 Hepatitis treatment centres in three years in the state under National Viral Hepatitis Control Programme (NVHCP) to treat such patients across the country, a statement from the state government said on Monday
.
Punjab Health Minister Balbir Singh Sidhu: Punjab was the first state to initiate free of cost treatment of Hepatitis C in the country. Till date, 1.83 lakh persons have been screened for Hepatitis C here and 91,403 patients have been initiated on free treatment of it. All 59 treatment centers are actively functional at 22 district hospitals, 3 GMCs, 13 ART centers, 11 OST sites, 9 central prisons and one SDH.
, Feb 12 (IANS) Ahead of the Kumbh Purva Vaishanav Baithak here, PepsiCo India on Friday provided more than 45,000 masks along with sanitisers as part of hygiene kits to police personnel deployed in this holy town.The event beginning on .
After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection of acute infection and 6 indirect (antibody) tests for detection of prior infection that meet the recently published World Health Organization (WHO) “desirable” Target Product Profile (TPP) criteria. The researchers hope their work will help communities and healthcare systems make more informed decisions when choosing rapid, point-of-care COVID-19 tests.
Image by Gerd Altmann from Pixabay
TPPs outline the desired characteristics of a product aimed at a specific disease. The WHO TPPs can be used to compare key features of COVID-19 tests and select products that best respond to the public health needs of each region.